Steve Elms, Director, 10% Owner at Loxo Oncology, Inc. (LOXO), bought 3,263,786 shares at $13.00 ($5.4M) on 2014-08-06, disclosed to the SEC on 2014-08-06.
Open-market purchase of $5.4M LOXO by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,850,709 | $0 | 0.0% |
| 2 | $13.00 | 413,077 | $5.4M | 100.0% |
| Total | $1.65 avg | 3,263,786 | $5.4M | 100% |
| Filing → |
| MRKR | BUY | 2024-12-26 | $35K | — | Filing → |
| ADMA | SELL | 2024-03-19 | $5.6M | — | Filing → |
| ADMA | SELL | 2024-03-15 | $10.2M | — | Filing → |